Providers/Grant Support
Jointly provided by Cornerstone Medical Education and American Academy of CME.
This activity is supported in part by an independent education grant from Abbott Diabetes Care.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
- Nurse Practitioners — 0.5 Nursing Contact Hours (0.4 pharmacotherapeutic contact hours)
- Nurses — 0.5 Nursing Contact Hours (0.4 pharmacotherapeutic contact hours)
- Pharmacists — 0.5 ACPE contact hours (0.05 CEUs)
- Physician Assistants — 0.5 AAPA Category 1 CME credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
Primary care physicians (PCPs), internal medicine physicians, endocrinologists, diabetologists, nurse practitioners (NPs), physician assistants (PAs), nurses, pharmacists, and other members of the interprofessional diabetes care team.
Program Overview
This educational activity is designed for the diabetes care team as a review of contemporary data on DKA prevalence, burden, risk, and trends. It aims to strengthen healthcare professionals’ ability to identify patients at higher risk for DKA and to monitor and manage them effectively.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Summarize data supporting the use of CGM to aid lifestyle changes.
- Evaluate strategies for overcoming barriers to CGM use in people with T2D.
- Describe the application of CGM devices for improving GLP-1 RA use in people with T2D.
Faculty
Eden Miller, DO
Chief Executive Officer
Diabetes and Obesity Care
Bend, Oregon
Eugene E. Wright, Jr, MD
Medical Director for Performance Improvement
South Piedmont Area Health Education Center
Charlotte, North Carolina
Carol H. Wysham, MD
Clinical Professor of Medicine
University of Washington School of Medicine
Spokane, Washington
Reviewers and Planners
Susan Cornell, PharmD, FADCES
Clinical Pharmacist, Certified Diabetes Care and Education Specialist
Professor Emeritus
Midwestern University
Downers Grove, Illinois
Natalie Kirkwood, RN, BSN, JD
Academy Planner
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Division of Endocrinology, Diabetes, and Bone & Mineral Disorders
Henry Ford Health
Detroit, Michigan
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Cornerstone Medical Education. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses
American Academy of CME, Inc., designates this educational activity for 0.5 ANCC contact hours (0.4 pharmacotherapeutic contact hours).
Pharmacists
This activity provides 0.5 ACPE contact hours (0.05 CEUs) of continuing education credit. Universal Activity Number JA4008191-9999-26-029-H01-P, Knowledge.
Physician Assistants
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until May 27, 2027. PAs should only claim credit commensurate with the extent of their participation.
Other HCPs
Other members of the care team will receive a certificate of participation.
Disclosures of Conflict of Interest
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Disclosure of relevant financial relationships are as follows:
Expert faculty report the following relationship(s) with ineligible companies:
Eden Miller, DO (Faculty) discloses the following relevant financial information with ineligible companies: Advisory Board/Consultant: Abbott, Boehringer Ingelheim, Lilly, Embecta, lnsulet, Novo Nordisk; Speaker’s Bureau: Abbott, Bayer, Boehringer Ingelheim, Corcept Therapeutics, Lilly, Embecta, lnsulet, Novo Nordisk
Eugene E. Wright, Jr, MD (Faculty) discloses the following relevant financial information with ineligible companies: Advisory Board/Consultant: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, Lilly, Sanofi; Speaker’s Bureau: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, Lilly, Sanofi; Intellectual Property/Patents: Glucose Patterns Insight Report in LibreView Abbott Diabetes Care
Carol H. Wysham, MD (Faculty) discloses the following relevant financial information with ineligible companies: Advisory Board/Consultant: Abbott Diabetes, Novo Nordisk, Lilly, Mannkind; Grant/Research Support: AbbVie, Bayer, Lilly, Novo Nordisk; Speaker's Bureau: Lilly, Novo Nordisk, Abbott Diabetes, Mannkind
Content reviewers report the following relationship(s):
Natalie Kirkwood, RN, BSN, JD has no relevant financial relationships with ineligible companies to disclose.
Susan Cornell, PharmD, CDCES, FAPhA, FADCES (Reviewer) discloses the following relevant financial information with ineligible companies: Advisory Board/Consultant: Novo Nordisk
Planning committee members report the following relationship(s):
Davida Kruger, MSN, APN-C, BC-ADM (Planner) discloses the following relevant financial information with ineligible companies: Advisory Board/Consultant: Dexcom, Insulet, Abbott Diabetes Care, Lilly, Tandem Diabetes Care, Sequel, CeQur, MannKind, Ascensia Diabetes Care, Arecor Therapeutics, Structural Therapeutics, Proteomics, Luna Diabetes; Grant/Research Support: Insulet, Abbott Diabetes Care, Tandem Diabetes Care, Sequel; Speaker’s Bureau: Dexcom, Insulet, Novo Nordisk, Lilly, Abbott Diabetes Care, Sequel, CeQur, Sanofi, Corcept Therapeutics
American Academy of CME and Cornerstone Medical Education Planners: No relevant financial relationships with ineligible companies to disclose.
Unlabeled and Investigational Usage
This activity will not review off-label or investigational information.
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or Cornerstone Medical Education. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Desktop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclosure of Unlabeled Use
This activity will not review off-label or investigational information.
Disclaimer
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or Cornerstone Medical Education. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Contact Information
For any CME-related questions, please contact: CEServices@academycme.org
For any content-related questions, please contact: info@cornerstonemeded.com